Blue Bird (BLBD) Is Up 7.5% After Taking Full Control of Micro Bird JV - Has The Bull Case Changed?

Blue Bird Corporation

Blue Bird Corporation

BLBD

0.00

  • Earlier this month, Blue Bird Corporation completed its acquisition of Girardin Group’s remaining stake in the Micro Bird joint venture for about US$201.8 million, moving to full ownership while issuing 2,702,180 exchangeable shares and appointing Steve Girardin to its Board of Directors through 2029.
  • This deal not only consolidates Blue Bird’s control over a key small-bus platform, but also tightly aligns the Girardin family’s long-term economic and voting interests with the company’s future direction.
  • We’ll now examine how full ownership of Micro Bird and the expanded EV-focused backlog could influence Blue Bird’s existing investment narrative.

AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

Blue Bird Investment Narrative Recap

To own Blue Bird, you need to believe in a long-term shift toward cleaner school transportation and the company’s ability to convert its healthy backlog into profitable growth. The biggest near term catalyst is continued demand for alternative fuel and electric buses supported by government funding, while a key risk remains policy and tariff volatility that could disrupt orders. The Micro Bird deal reinforces Blue Bird’s control of a core platform but does not materially change these near term drivers.

The acquisition of Girardin’s remaining stake in Micro Bird connects directly to Blue Bird’s push into higher value, alternative powered and EV offerings, including an expanded small bus range. That aligns with recent results highlighting record EV backlogs and ongoing investments in plant automation and a new Micro Bird facility. Together, these developments strengthen the company’s ability to execute on its clean bus and efficiency catalysts, even as it manages funding and policy uncertainty.

But while the upside around clean bus funding looks appealing, investors also need to be aware that...

Blue Bird's narrative projects $1.7 billion revenue and $167.2 million earnings by 2029.

Uncover how Blue Bird's forecasts yield a $69.29 fair value, a 10% upside to its current price.

Exploring Other Perspectives

BLBD 1-Year Stock Price Chart
BLBD 1-Year Stock Price Chart

Some of the most optimistic analysts were already assuming revenue of about US$1.6 billion and earnings near US$159 million by 2028, yet the Micro Bird acquisition and your view on risks like government funding dependence and public budget pressure could easily shift how credible that more aggressive narrative now feels.

Explore 4 other fair value estimates on Blue Bird - why the stock might be worth as much as 64% more than the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Blue Bird research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
  • Our free Blue Bird research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Blue Bird's overall financial health at a glance.

No Opportunity In Blue Bird?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

  • Invest in the nuclear renaissance through our list of 93 elite nuclear energy infrastructure plays powering the global AI revolution.
  • Find 58 companies with promising cash flow potential yet trading below their fair value.
  • The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.